Improving quality of life. With innovations for ophthalmology and microsurgery, we are contributing to progress in medicine. Our products and solutions aim to help physicians to improve patient outcomes.

ZEISS Medical Technology


The Carl Zeiss Meditec AG is listed on the MDAX and TecDAX of the German stock exchange (ISIN DE 0005313704); 59 percent of the shares are held by Carl Zeiss AG. The remaining shares are in free float.


Besides its headquarters in Jena/ Germany, the Carl Zeiss Meditec has subsidiaries in the USA, Japan, Germany, Spain, France, Turkey and UK. Additional ZEISS Research and Development Centers in India and China strengthen the company's presence in these rapidly developing economies. In other countries the company makes use of the vaste distribution network of ZEISS.

Management board

Dr. Ludwin Monz (President and CEO)
Justus Felix Wehmer
Jan Willem de Cler


In fiscal year 2017/18, €1,280.9 million1


The Carl Zeiss Meditec Group has about 3,050 employees worldwide, including around 400 at the headquarters in Jena (as of September 30, 2018).1

The Medical Technology segment of ZEISS offers complete solutions to diagnose and treat ophthalmic diseases. In the field of microsurgery the company provides innovative visualization solutions.

With a special focus on ophthalmology, ophthalmic surgery and visualization systems in the field of microsurgery, the company supports healthcare professionals in setting new standards of care with proven medical technology and broad application competence based on cutting-edge innovations. ZEISS also offers visualization solutions for dental treatment and gynecology. The company's medical technology portfolio is completed by future-oriented technologies such as intraoperative radiotherapy.

Through our global network we are well aware of our customers’ demands. Worldwide neurosurgeons, ear, nose and throat specialist and ophthalmologists – if there are clinicians or if they are office-based – put their trust in the know-how of ZEISS. We are playing in active role in the rapidly proceeding digitalization of the medical sector by offering software solutions for simple and effective patient data management.

The market launch of the slit lamp in 1912 heralded the dawn of the medical technology business at ZEISS. It was just the first of many pioneering inventions in the fields of ophthalmology, microscopy and radiotherapy. Today the Medical Technology activities of ZEISS are today largely bundled under the umbrella of the TecDAX-listed company Carl Zeiss Meditec AG in which Carl Zeiss AG holds ca. 65 percent interest.

Locations and directions

Find your local sales and service contact

Company information

More about Carl Zeiss Meditec AG